HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tolerance to vancomycin in pneumococci: detection with a molecular marker and assessment of clinical impact.

AbstractBACKGROUND:
Vancomycin is often added to therapy for meningitis caused by Streptococcus pneumoniae. Tolerant bacteria without classic resistance that escape killing by multiple antibiotics have been reported sporadically. We determined the prevalence of tolerance to vancomycin in pneumococci and its effect on the outcome of meningitis.
METHODS:
Archival samples of 215 nasopharyngeal (NP) and 113 meningitis isolates were tested for the killing efficacy of vancomycin. Specific DNA sequence changes in a transporter locus were identified for tolerant isolates. Similar tests were conducted prospectively on 517 NP isolates from healthy children.
RESULTS:
In archival isolates, tolerance to vancomycin was detected in 3.7% of NP and 10.6% of invasive isolates. Patients with meningitis caused by tolerant isolates had a worse estimated 30-day survival than did patients with meningitis caused by nontolerant isolates (49% vs. 86%; P = .048); 62.5% of tolerant archival NP isolates harbored a specific sequence change for pep27 and vex2 (P = .021). Prospective analysis of 517 carriage isolates indicated that 8.1% were tolerant to vancomycin and that 82.1% of tolerant isolates harbored the specified marker gene sequences (P = .001).
CONCLUSIONS:
Tolerance to vancomycin exists in the population of pneumococci. Tolerant isolates are associated with meningitis of increased mortality, and these isolates can be tracked by specific marker sequences in 2 genes.
AuthorsCarina A Rodriguez, Robyn Atkinson, Wally Bitar, Cynthia G Whitney, Kathryn M Edwards, Lauren Mitchell, Juan Li, Jack Sublett, Chin-Shang Li, Tiebin Liu, P Joan Chesney, Elaine I Tuomanen
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 190 Issue 8 Pg. 1481-7 (Oct 15 2004) ISSN: 0022-1899 [Print] United States
PMID15378442 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
CopyrightCopyright 2004 Infectious Diseases Society of America
Chemical References
  • Anti-Bacterial Agents
  • Genetic Markers
  • Vancomycin
  • Protein Kinases
  • VncS histidine kinase
  • N-Acetylmuramoyl-L-alanine Amidase
Topics
  • Alleles
  • Anti-Bacterial Agents (pharmacology, therapeutic use)
  • Carrier State (microbiology)
  • Child
  • Drug Resistance (genetics)
  • Female
  • Genes, Bacterial
  • Genetic Markers
  • Humans
  • Male
  • Meningitis (drug therapy, microbiology, mortality)
  • N-Acetylmuramoyl-L-alanine Amidase (genetics)
  • Nasopharynx (microbiology)
  • Polymorphism, Single Nucleotide
  • Protein Kinases (genetics)
  • Streptococcus pneumoniae (drug effects, genetics, isolation & purification)
  • Survival Analysis
  • Vancomycin (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: